Boston Scientific Corporation
BSX
$100.02
$0.970.98%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.28B | 534.00M | 725.00M | 414.00M | 2.50B |
| Total Receivables | 2.83B | 2.82B | 2.69B | 2.56B | 2.50B |
| Inventory | 2.92B | 2.86B | 2.87B | 2.81B | 2.75B |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.01B | 911.00M | 1.05B | 1.14B | 1.01B |
| Total Current Assets | 8.04B | 7.12B | 7.34B | 6.92B | 8.76B |
|
|
|||||
| Total Current Assets | 8.04B | 7.12B | 7.34B | 6.92B | 8.76B |
| Net Property, Plant & Equipment | 4.29B | 3.95B | 3.84B | 3.74B | 3.50B |
| Long-term Investments | 18.21B | 18.08B | 17.34B | 17.09B | 15.03B |
| Goodwill | 18.21B | 18.08B | 17.34B | 17.09B | 15.03B |
| Total Other Intangibles | 7.16B | 7.26B | 6.57B | 6.68B | 5.76B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.36B | 4.52B | 4.41B | 4.40B | 4.50B |
| Total Assets | 42.71B | 41.56B | 40.14B | 39.40B | 38.08B |
|
|
|||||
| Total Accounts Payable | 1.00B | 962.00M | 1.00B | 960.00M | 907.00M |
| Total Accrued Expenses | 2.75B | 2.59B | 2.10B | 2.53B | 2.27B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 483.00M | 480.00M | 777.00M | 1.86B | 1.65B |
| Total Finance Division Other Current Liabilities | 1.09B | 1.16B | 1.17B | 1.05B | 1.08B |
| Total Other Current Liabilities | 1.09B | 1.16B | 1.17B | 1.05B | 1.08B |
| Total Current Liabilities | 5.33B | 5.19B | 5.06B | 6.40B | 5.91B |
|
|
|||||
| Total Current Liabilities | 5.33B | 5.19B | 5.06B | 6.40B | 5.91B |
| Long-Term Debt | 10.99B | 10.98B | 10.41B | 8.84B | 9.23B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 570.00M | 566.00M | 525.00M | 527.00M | 377.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.19B | 2.17B | 1.71B | 1.62B | 1.61B |
| Total Liabilities | 19.08B | 18.91B | 17.70B | 17.39B | 17.12B |
|
|
|||||
| Common Stock & APIC | 21.44B | 21.25B | 21.14B | 21.07B | 20.98B |
| Retained Earnings | 4.90B | 4.14B | 3.35B | 2.67B | 2.11B |
| Treasury Stock & Other | -2.94B | -2.97B | -2.28B | -1.98B | -2.38B |
| Total Common Equity | 23.39B | 22.42B | 22.21B | 21.77B | 20.71B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 23.39B | 22.42B | 22.21B | 21.77B | 20.71B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 236.00M | 235.00M | 233.00M | 233.00M | 248.00M |
| Total Equity | 23.63B | 22.65B | 22.45B | 22.00B | 20.96B |
|
|
|||||